Zacks Investment Research upgraded shares of Ipsen Sa Adr (OTCMKTS:IPSEY) from a hold rating to a strong-buy rating in a research report released on Monday, July 31st. They currently have $38.00 price target on the stock.
According to Zacks, “Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. “
Ipsen Sa Adr (IPSEY) traded down 0.69% during midday trading on Monday, reaching $31.62. The company had a trading volume of 343 shares. The stock has a market capitalization of $10.41 billion and a PE ratio of 40.54. The firm’s 50 day moving average is $32.95 and its 200 day moving average is $27.77. Ipsen Sa Adr has a 1-year low of $15.94 and a 1-year high of $35.71.
COPYRIGHT VIOLATION NOTICE: “Ipsen Sa Adr (OTCMKTS:IPSEY) Upgraded by Zacks Investment Research to “Strong-Buy”” was published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thestockobserver.com/2017/08/12/ipsen-sa-adr-otcmktsipsey-stock-rating-upgraded-by-zacks-investment-research-updated.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ipsen Sa Adr Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ipsen Sa Adr and related companies with MarketBeat.com's FREE daily email newsletter.